Please make notes on subcutaneous icd
Reading File
Finding Sources
Finding Sources
Searching PubMed
"subcutaneous ICD" AND implantable cardioverter defibrillator
Reading File
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Loading Image
Reading File
I now have comprehensive information to compile detailed notes. Let me put these together:
Subcutaneous ICD (S-ICD) - Clinical Notes
Sources: Braunwald's Heart Disease 12e, Miller's Anesthesia 10e
What is an S-ICD?
The subcutaneous ICD is a fully extrathoracic defibrillation system - neither the pulse generator nor the lead enters the vasculature or heart. It was initially approved in 2012 for defibrillation therapy in patients at risk for malignant ventricular arrhythmias. The current commercially available device is manufactured by Boston Scientific Inc.
Device Anatomy
The system consists of two components:
- Pulse generator - implanted between the anterior and midaxillary lines at the level of the 6th intercostal space on the left chest
- Single subcutaneous lead - tunneled medially from the pulse generator pocket to the xiphoid process, then superiorly along the left parasternal border
The lead carries:
- A distal sensing electrode
- A shock coil
- A proximal sensing electrode
Chest X-ray appearance of an implanted S-ICD (PA and lateral views):
What the S-ICD CAN and CANNOT Do
| Feature | S-ICD |
|---|---|
| Detect and shock VF/VT | YES |
| Post-shock backup pacing (50 ppm x 30 sec) | YES |
| Long-term bradycardia pacing | NO |
| Antitachycardia pacing (ATP) | NO |
| Cardiac resynchronization therapy (CRT) | NO |
Future models are expected to communicate wirelessly with leadless capsule pacemakers (Boston Scientific's Empower LP is in trials). This "modular cardiac rhythm management" would allow the S-ICD to trigger ATP through the leadless pacemaker.
Pre-implant ECG Screening
All candidates undergo pre-implant screening using surface ECG electrodes to assess risk of:
- T-wave oversensing
- R-wave double-counting
About 7-10% of candidates fail screening and are not suitable for S-ICD.
Advantages over Transvenous ICD
- Eliminates vascular access complications (pneumothorax, cardiac perforation, hemothorax)
- No intravascular/lead infection risk; no risk of lead-associated endocarditis
- Implantation is possible without fluoroscopy
- Lead extraction is simpler and safer (entirely subcutaneous)
- Lead failure may be less common
- Well-suited for MRI: no transvenous lead complications during scanning
Disadvantages vs Transvenous ICD
- Higher rate of inappropriate shocks (5-10% vs <2% in first year for transvenous ICDs), though newer sensing algorithms have reduced this
- Cannot deliver ATP, bradycardia pacing, or CRT
- Requires pre-implant ECG screening (7-10% fail)
- Higher defibrillation thresholds (DFTs) - defibrillation testing at implant is recommended (unlike transvenous, where testing can often be omitted)
- Larger pulse generator
- Shorter battery longevity (relative)
- Slower charge time vs modern transvenous devices
Patient Selection
Preferred Candidates for S-ICD
- Limited vascular access (e.g., dialysis patients)
- History or high risk of intravascular infection (e.g., prosthetic heart valves, prior CIED infection)
- Intracardiac shunt (where transvenous leads carry risk of paradoxical embolism)
- Young patients - easier lead extraction long-term, potentially greater lead longevity
- Brugada syndrome - lead-related complications are a real concern in this group
NOT candidates for S-ICD (need transvenous instead)
- Need for bradycardia pacing
- Need for ATP to manage VT
- Need for CRT (resynchronization)
- Fail pre-implant ECG screening
Complications
| Complication | Notes |
|---|---|
| Vascular access complications (pneumothorax, cardiac perforation) | NOT applicable - extrathoracic |
| Pocket infection | ~1.1% in large series; trend toward lower total infections than transvenous (Praetorian trial) |
| Systemic/intravascular infection | Not reported in S-ICD |
| Inappropriate shocks | Reduced with new sensing algorithms but still higher than transvenous |
Sensing and EGMs
The S-ICD records subcutaneous EGMs from one of three sensing vectors:
- Primary vector
- Secondary vector (prone to myopotential artifact - overlies pectoralis muscles)
- Alternate vector (smallest amplitude - often overlies atrial tissue and sternum)
Perioperative / Magnet Behavior
The S-ICD responds to a magnet similarly to a standard Boston Scientific ICD:
- Magnet application over the pulse generator suspends arrhythmia detection and shock therapy
- A beeping sound confirms correct magnet positioning (stops after 60 seconds, but therapy remains suspended while magnet is in place)
- Removing the magnet reverts the device to its prior programmed state
- In the perioperative setting, preferred approach is to reprogram the device (turn off antitachycardic function) and place defibrillator pads
Defibrillation Testing at Implant
- Recommended for all S-ICD implants because DFTs are higher with subcutaneous shock vectors
- This differs from transvenous ICDs (left pectoral), where DFT testing can reasonably be omitted when lead position, sensing, and impedance are confirmed by fluoroscopy
Key Clinical Trials
- Praetorian trial - compared S-ICD vs transvenous ICD; showed a trend toward lower total infections with S-ICD
- A 2026 systematic review (PMID: 42171458 - Zweibel et al., J Med Econ) reviewed acute and long-term outcomes in patients with non-transvenous ICDs
Braunwald's Heart Disease 12e, Chapter 69 | Miller's Anesthesia 10e, Chapter on Emerging Technologies
Please provide images on subcutaneous icd and convert above into notes
Reading File
Finding Sources
Finding Sources
Searching the Web
subcutaneous ICD S-ICD images diagram anatomy lead placement screening
Loading Image
Loading Image
Loading Image
Loading Image
Running Command
Writing File
Running Command
Running Command
Running Command
Your Word document is ready:
Subcutaneous ICD Notes
Word Document · DOCX
Here is a preview of all the images included in the notes:
Figure 1 - S-ICD vs Transvenous ICD anatomy (Nature Reviews Cardiology):
Figure 2 - ECG Screening Vectors (electrode positions):
Figure 3 - S-ICD full comparison table with anatomy (Braunwald's 12e, eTable 69.4):
Figure 4 - Chest X-ray of implanted S-ICD (Braunwald's 12e, Fig 69.5):
The document contains 11 sections with color-coded headings, formatted tables, and all 4 images embedded:
| Section | Content |
|---|---|
| 1 | Overview & approval history |
| 2 | Device anatomy, components, implant technique |
| 3 | Capabilities table (S-ICD vs transvenous) |
| 4 | Pre-implant ECG screening |
| 5 | Patient selection (indications & contraindications) |
| 6 | Sensing vectors, inappropriate shocks |
| 7 | Defibrillation & shock therapy |
| 8 | Complications (with Praetorian trial) |
| 9 | Perioperative management & magnet behavior |
| 10 | Key numbers quick reference table |
| 11 | Recent evidence & trials |
This is a shared conversation. Sign in to Orris to start your own chat.